Minegishi, Y., Kiyotani, K., Nemoto, K., Inoue, Y., Haga, Y., Fujii, R., Saichi, N., Nagayama, S. and Ueda, K. Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations.
Commun. Biol., in press (2022) |
Ochiai, R., Hayashi, K., Yamamoto, H., Fujii, R., Saichi, N., Shinchi, H., Ishida, T., Honda, T., Shimizu, T., Matsutani, N., Seki, N., Kawamura, M. and Ueda, K. Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment.
Cancer Sci., in press (2022) |
Namikawa, K., Tanaka, N., Ota, Y., Takamatsu, M., Kosugi, M., Tokai, Y., Yoshimizu, S., Horiuchi, Y., Ishiyama, A., Yoshio, T., Hirasawa, T., Amino, S., Furuya, R., Gotoh, O., Kaneyasu, T., Nakayama, I., Imamura, Y., Noda, T., Fujisaki, J. and Mori, S. Genomic features of Helicobacter pylori-naïve diffuse-type gastric cancer.
J. Pathol., in press (2022) |
Sakashita, T., Yanagitani, N., Koike, S., Low, S. K., Takagi, S., Baba, S., Takeuchi, K., Nishio, M., Fujita, N. and Katayama, R. Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
Cancer Sci., in press (2022) |
Fukuoka, M., Ichikawa, Y., Osako, T., Fujita, T., Baba, S., Takeuchi, K., Tsunoda, N., Ebata, T., Ueno, T., Ohno, S. and Saitoh, N. The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.
Cancer Sci., in press (2022) |
Igarashi, N., Miyata, K., Loo, T. M., Chiba, M., Hanyu, A., Nishio, M., Kawasaki, H., Zheng, H., Toyokuni, S., Kon, S., Moriyama, K., Fujita, Y. and Takahashi, A. Hepatocyte growth factor derived from senescent cells attenuates cell competition-induced apical elimination of oncogenic cells.
Nat. Commun., in press (2022) |
Kunimasa, K., Ikeda-Ishsikawa, C., Tani, Y., Tsukahara, S., Sakurai, J., Okamoto, Y., Koido, M., Dan, S. and Tomida, A. Spautin-1 inhibits mitochondrial complex I and leads to suppression of the unfolded protein response and cell survival during glucose starvation.
Sci. Rep., 12, 11533 (2022) |
Shimizu, Y., Maruyama, K., Suzuki, M., Kawachi, H., Low, S. K., Oh-Hara, T., Takeuch, K., Fujita, N., Nagayama, S. and Katayama, R. Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma.
Cancer Lett., in press (2022) |
Ebata, H., Loo, T. M. and Takahashi, A. Telomere maintenance and the cGAS-STING pathway in cancer.
Cells, in press (2022) |
Kumegawa, K., Takahashi, Y., Saeki, S., Yang, L., Nakadai, T., Osako, T., Mori, S., Noda, T., Ohno, S., Ueno, T. and Maruyama, R. GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer.
NPJ Breast Cancer, 8, 70 (2022) |
